Chemotherapy of leishmaniasis: past, present and future.
about
Proteomic analysis of the secretome of Leishmania donovaniRecent developments in drug discovery for leishmaniasis and human African trypanosomiasisCrystal structure of the Leishmania major phosphodiesterase LmjPDEB1 and insight into the design of the parasite-selective inhibitorsX-ray Structure of 4,4'-Dihydroxybenzophenone Mimicking Sterol Substrate in the Active Site of Sterol 14 -Demethylase (CYP51)Trypanosoma cruzi CYP51 Inhibitor Derived from a Mycobacterium tuberculosis Screen HitIn vitro and in vivo efficacy of ether lipid edelfosine against Leishmania spp. and SbV-resistant parasitesHemolytic phospholipase C inhibition protects lung function during Pseudomonas aeruginosa infectionChemotherapeutic potential of 17-AAG against cutaneous leishmaniasis caused by Leishmania (Viannia) braziliensisSterol 14alpha-demethylase (CYP51) as a therapeutic target for human trypanosomiasis and leishmaniasisMetabolic network analysis predicts efficacy of FDA-approved drugs targeting the causative agent of a neglected tropical diseaseDrought, smallpox, and emergence of Leishmania braziliensis in northeastern Brazil.IN VIVO AND IN VITRO ANTILEISHMANIAL EFFECTS OF METHANOLIC EXTRACT FROM BARK OF BURSERA APTERA.In vitro and in vivo efficacy of novel flavonoid dimers against cutaneous leishmaniasis.Preparation and evaluation of niosomes containing autoclaved Leishmania major: a preliminary study.Pharmacotherapeutic options for visceral leishmaniasis-current scenario.Update in the treatment of cutaneous leishmaniasis.The antileishmanial activity of isoforms 6- and 8-selective histone deacetylase inhibitors.Differential effects of paromomycin on ribosomes of Leishmania mexicana and mammalian cellsDrug strategies targeting CYP51 in neglected tropical diseasesTransgenic expression of CXCR3 on T cells enhances susceptibility to cutaneous Leishmania major infection by inhibiting monocyte maturation and promoting a Th2 response.In vitro sensitivity of paired Leishmania (Viannia) braziliensis samples isolated before meglumine antimoniate treatment and after treatment failure or reactivation of cutaneous leishmaniasisMolecular factors governing inhibition of arylimidamides against Leishmania: conservative computational modeling to improve chemotherapies.Spermidine synthase is required for virulence of Leishmania donovani.Use of antimony in the treatment of leishmaniasis: current status and future directions.Antiparasitic activity of plumericin & isoplumericin isolated from Plumeria bicolor against Leishmania donovani.Discovery of safe and orally effective 4-aminoquinaldine analogues as apoptotic inducers with activity against experimental visceral leishmaniasis.Trypanocidal and leishmanicidal activities of sesquiterpene lactones from Ambrosia tenuifolia Sprengel (Asteraceae).Cytotoxicity and In Vitro Antileishmanial Activity of Antimony (V), Bismuth (V), and Tin (IV) Complexes of Lapachol.Evaluation of toxicity & therapeutic efficacy of a new liposomal formulation of amphotericin B in a mouse modelAn alternative in vitro drug screening test using Leishmania amazonensis transfected with red fluorescent protein.Leishmania donovani ornithine decarboxylase is indispensable for parasite survival in the mammalian host.Methylene tetrahydrofolate dehydrogenase/cyclohydrolase and the synthesis of 10-CHO-THF are essential in Leishmania major.β-Nitrostyrenes as Potential Anti-leishmanial Agents.Potent inhibition of human apurinic/apyrimidinic endonuclease 1 by arylstibonic acids.A novel organotellurium compound (RT-01) as a new antileishmanial agent.Diarylamidines: high potency inhibitors of acid-sensing ion channels.Drug delivery strategies for therapy of visceral leishmaniasis.Photodynamic antimicrobial chemotherapy (PACT) for the treatment of malaria, leishmaniasis and trypanosomiasis.Structure, function, and pharmacology of acid-sensing ion channels (ASICs): focus on ASIC1a.FasL and TRAIL signaling in the skin during cutaneous leishmaniasis - implications for tissue immunopathology and infectious control
P2860
Q21184106-9E80CF63-532B-427B-888B-D3852A6776CEQ27011766-FD24C199-C2D6-467E-9EE7-62E51428104CQ27648821-5B4D9E12-98D0-476C-B14F-6754EA45D9FFQ27650159-0DD83A97-F2C2-48CE-8E2F-2EA919EF7166Q27653636-ECBAB3AF-C56A-406C-B298-39D2360F9FE0Q28482212-B405F1B9-6411-4879-B7C3-A8FEDD20B390Q28492881-41AAAD17-D1ED-46C3-8EE6-CB4B374ED82DQ28544030-898031C5-EE30-47C4-A918-771E3162BF9CQ28727454-C38924E0-079C-4057-A5E8-A810CE9D9C7BQ30426102-38B2F44C-F5BC-481D-ADE8-8142D3076558Q30438890-B34DB36B-B812-4C52-857E-E2F653D739DFQ33732878-98C7C7A1-1AC9-48BF-AA84-175281F03148Q33797896-03F721F4-7C18-49A3-84BE-09AA356968CCQ34093684-7D895A85-8675-4B07-8E2A-13FE6E9D05ADQ34342651-1B86B10D-F39A-4E82-A2EE-DCC5B7303376Q34421618-8E2533DA-DF2B-4C45-8C69-3790087C40DCQ34479028-31F0B0CD-3650-424D-9E5D-6C2DE94A3DF4Q34483607-A95F3750-5069-4290-9ACB-3785580AFD53Q34622554-E5F8782B-C8A1-4163-8FAC-02CCA82E121BQ34890041-5EDD3440-E9CA-47D1-9088-B76E27BA98F4Q35087276-C1127CD4-97B1-47E1-B9E0-3C761E6AEFABQ35189818-10B3E8D6-6F64-4C61-A065-D2688D51B7C2Q35328673-F6E023B9-9F29-49D8-9108-A1334D09EA62Q35377767-82327EFA-332F-4761-B79D-5EF921194151Q35646926-6C3C3F6E-139E-48F0-B7B6-41F625FBB3F5Q35666558-8B92D24D-4A51-4A8E-8668-7A1A984C45BDQ36744744-3D82F208-7F41-46A2-87C3-EE29C5CA52B4Q36916045-8D39C8B2-B019-4083-9F1A-2842142AE050Q37047243-53372444-2BE3-4B28-A4BF-CE9C0CB10C97Q37069597-BF091589-4D8B-49F5-AD6E-AC57272E872BQ37075493-6E6C29A5-F781-4F58-A855-11837C57FD4AQ37217438-47E2EAB4-B5FC-407F-8C08-8320BCB0EC49Q37224367-9276C24F-0C3B-4648-8EA2-11562E21B4CBQ37288467-2E03E32D-616F-4D1D-B35B-A9B8EAB197BFQ37327788-2758CAE6-B9F5-46B4-B178-8B81C03C86EAQ37356377-E7DF3E3E-8D8E-4368-AE00-53FDDE1336B3Q37702257-899AD23F-497A-44FB-A117-C5DDF518C321Q37820273-C1AAED25-7F6D-4484-A4D0-1662ECF9D165Q37850687-3AE0AAB7-876A-4CF8-B176-D2065E4382A7Q38020837-2B5B6365-4D21-4D7D-8257-DE8BE9D86F38
P2860
Chemotherapy of leishmaniasis: past, present and future.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Chemotherapy of leishmaniasis: past, present and future.
@ast
Chemotherapy of leishmaniasis: past, present and future.
@en
type
label
Chemotherapy of leishmaniasis: past, present and future.
@ast
Chemotherapy of leishmaniasis: past, present and future.
@en
prefLabel
Chemotherapy of leishmaniasis: past, present and future.
@ast
Chemotherapy of leishmaniasis: past, present and future.
@en
P2093
P1476
Chemotherapy of leishmaniasis: past, present and future.
@en
P2093
Anubha Saxena
Jyotsna Mishra
Sarman Singh
P304
P356
10.2174/092986707780362862
P577
2007-01-01T00:00:00Z